HR 2940 118th Congress House Health Administrative law and regulatory procedures Advanced technology and technological innovations Advisory bodies Appropriations Department of Health and Human Services Drug therapy Executive agency funding and structure Government information and archives Government studies and investigations Health information and medical records Infectious and parasitic diseases Medical research Prescription drugs Public contracts and procurement Research and development

PASTEUR Act

Introduced: July 10, 2023 See on congress.gov

Everywhere this bill has been 4 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Dec 17, 2024

Referred to the Subcommittee on Health.

Apr 28, 2023

Referred to the Subcommittee on Health.

Apr 27, 2023

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Oversight and Accountability, Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Apr 27, 2023

Introduced in House

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Plain-English summary Congressional Research Service

Pioneering Antimicrobial Subscriptions To End Upsurging Resistance Act of 2023 or the PASTEUR Act of 2023

This bill authorizes the Department of Health and Human Services (HHS) to enter into subscription contracts for critical-need antimicrobial drugs, provides $6 billion in appropriations for activities under the bill, and contains other related provisions.

A manufacturer of a Food and Drug Administration-approved antimicrobial drug may apply to HHS to have the drug designated as a critical-need antimicrobial, and HHS may enter into a subscription contract for such a critical-need antimicrobial. The bill imposes certain requirements related to such contracts, including a mechanism to lower payments under the contract in certain instances to limit the manufacturer's revenue from the drug.

Furthermore, HHS and the Centers for Disease Control and Prevention (CDC) shall award grants to support efforts to encourage the appropriate use of antimicrobial drugs and efforts to combat antimicrobial resistance. The CDC shall also track and assess data relating to antibacterial resistance and human antibiotic use and make such data publicly available.

HHS shall also establish a Committee on Critical Need Antimicrobials. The committee shall develop a list of prioritized infections for which new antimicrobial drug development is needed, among other duties.

Within six years of the bill's enactment, the Government Accountability Office shall report to Congress a study on the bill's effectiveness in developing priority antimicrobial drugs.

What's happening now December 17, 2024

Referred to the Subcommittee on Health.

Related & companion bills 1

Bill text 1 version

Introduced in House Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 6

Budget Committee
House of Representatives
Energy and Commerce Committee
House of Representatives
Health Subcommittee
House of Representatives · subcommittee of Energy and Commerce Committee
Health Subcommittee
House of Representatives · subcommittee of Ways and Means Committee
Oversight and Government Reform Committee
House of Representatives
Ways and Means Committee
House of Representatives

Lobbying activity 6

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

HEALTHCARE INSTITUTE OF NEW JERSEY
for HEALTHCARE INSTITUTE OF NEW JERSEY · New Jersey · 2nd Quarter (Apr 1 - June 30) 2026
HEALTHCARE INSTITUTE OF NEW JERSEY
for HEALTHCARE INSTITUTE OF NEW JERSEY · New Jersey · 1st Quarter (Jan 1 - Mar 31) 2026
HEALTHCARE INSTITUTE OF NEW JERSEY
for HEALTHCARE INSTITUTE OF NEW JERSEY · New Jersey · 4th Quarter (Oct 1 - Dec 31) 2025
HEALTHCARE INSTITUTE OF NEW JERSEY
for HEALTHCARE INSTITUTE OF NEW JERSEY · New Jersey · 3rd Quarter (July 1 - Sep 30) 2025
HEALTHCARE INSTITUTE OF NEW JERSEY
for HEALTHCARE INSTITUTE OF NEW JERSEY · New Jersey · 2nd Quarter (Apr 1 - June 30) 2025
HEALTHCARE INSTITUTE OF NEW JERSEY
for HEALTHCARE INSTITUTE OF NEW JERSEY · New Jersey · 1st Quarter (Jan 1 - Mar 31) 2025